Proteomics

Dataset Information

0

SERPA: Autoantibody profiling in POAG


ABSTRACT: Glaucoma is the leading cause of irreversible blindness worldwide. An early diagnosis of the disease is crucial for treatment success. Mechanisms behind glaucoma pathogenesis are not completely understood, but disease related alterations in the serological autoantibody profile indicate an immunologic component. These changes in immunoreactivity may serve as potential biomarkers. Therefore, a serological proteome analysis (SERPA) approach was used to identify novel autoantibody biomarker candidates in primary open angle glaucoma. Autoantibodies in individual sera samples of glaucoma patients and control were analysed by serological proteome analysis (SERPA) using porcine trabecular meshwork (TM) tissue lysates as antigen source. Immunoblot spot intensities were computed by “Delta2D” (Decodon) and spots of interest were matched with preparative 2DE gels and identified by mass spectrometry to identify the potential autoantigens.

INSTRUMENT(S): LTQ Orbitrap XL

ORGANISM(S): Sus Scrofa Domesticus (domestic Pig)

TISSUE(S): Eye

SUBMITTER: Vanessa Beutgen  

LAB HEAD: Franz H. Grus

PROVIDER: PXD011752 | Pride | 2019-02-21

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
ID26659.RAW Raw
ID26659.msf Msf
ID27206.RAW Raw
ID27206.msf Msf
ID313.RAW Raw
Items per page:
1 - 5 of 32
altmetric image

Publications

Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA).

Beutgen Vanessa M VM   Perumal Natarajan N   Pfeiffer Norbert N   Grus Franz H FH  

Frontiers in immunology 20190307


Glaucoma is an optic neurological disorder and the leading cause of irreversible blindness worldwide, with primary open angle glaucoma (POAG) as its most prevalent form. An early diagnosis of the disease is crucial to prevent loss of vision. Mechanisms behind glaucoma pathogenesis are not completely understood, but disease related alterations in the serological autoantibody profile indicate an immunologic component. These changes in immunoreactivity may serve as potential biomarkers for glaucoma  ...[more]

Similar Datasets

| PRJNA926314 | ENA
| PRJNA194538 | ENA
2012-10-06 | E-MEXP-3427 | biostudies-arrayexpress
2012-09-08 | E-MEXP-3435 | biostudies-arrayexpress
2012-10-06 | E-MEXP-3439 | biostudies-arrayexpress
2012-09-08 | E-MEXP-3434 | biostudies-arrayexpress
2024-02-16 | E-MTAB-13771 | biostudies-arrayexpress
2023-03-14 | PXD038765 | Pride
2019-12-30 | E-MTAB-8157 | biostudies-arrayexpress
2012-05-08 | E-GEOD-37830 | biostudies-arrayexpress